The broader socio-economic value of adult respiratory disease vaccinations in the UK – results from a benefit cost analysis

The broader socio-economic value of adult respiratory disease vaccinations in the UK – results from a benefit cost analysis

Background Respiratory infections such as pneumococcal disease (PD), RSV, influenza (flu), and COVID-19 impose a major socio-economic burden in the UK. Adult vaccination programs cost-effectively reduce this burden, yet their societal value remains under-assessed.Methods A benefit–cost analysis (BCA...

Full description

Saved in:
Bibliographic Details
Main Authors: Cale Harrison, Simon Brassel, Sulayman Chowdhury, Claud Theakston, Matthew Napier, Jeffrey Vietri, Diana Mendes, Jingyan Yang, Tianyan Hu, Lotte Steuten
Format: Article
Language:English
Published: Taylor & Francis Group 2025-12-01
Series:Expert Review of Vaccines
Subjects:
Respiratory infection
adult vaccination
benefit–cost analysis
broader value of vaccines
societal net benefits
Online Access:https://www.tandfonline.com/doi/10.1080/14760584.2025.2536093
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://www.tandfonline.com/doi/10.1080/14760584.2025.2536093

Similar Items